ArticleOncotarget2015

Potent efficacy of metronomic topotecan and pazopanib combination therapy in preclinical models of primary or late stage metastatic triple-negative breast cancer.

Teresa Di Desidero et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.